CR Ventures logo

CR Ventures

Asia, Central Region, Singapore, Singapore

Description

CR Ventures is a global life-science investor with a focus on pharmaceutical, diagnostic, and other medical technology clinical trials.

Investor Profile

CR Ventures has made 3 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (67%)
  • Seed (33%)

Country Focus

  • United States (67%)
  • Switzerland (33%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Clinical Trials
  • Therapeutics
  • Health Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does CR Ventures frequently co-invest with?

Sidecar Angels
North America, Massachusetts, United States, Somerville
Co-Investments: 2
Boston Harbor Angels
North America, Massachusetts, United States, Boston
Co-Investments: 2
TI
Asia, Shanghai, China, Shanghai
Co-Investments: 1
DV
North America, Massachusetts, United States, Boston
Co-Investments: 1
DeepWork Capital
North America, Florida, United States, Orlando
Co-Investments: 1
Life Science Angels
North America, California, United States, Sunnyvale
Co-Investments: 1
Co-Investments: 2
Mid Atlantic Bio Angels
North America, New York, United States, New York
Co-Investments: 1
Mass Medical Angels
North America, Massachusetts, United States, Boston
Co-Investments: 1
Kyto Technology and Life Science Inc
North America, California, United States, Los Altos Hills
Co-Investments: 1

What are some of recent deals done by CR Ventures?

Adiposs

Geneva, Geneve, Switzerland

Adiposs SA is a clinical-stage life science company a first-in-class disruptive imaging product for cancer patients.

Biotechnology
SeedDec 24, 2021
Amount Raised: $1,955,593
Xeno Biosciences

Somerville, Massachusetts, United States

Xeno Biosciences is a biotechnology company that provides novel class of treatments for metabolic diseases.

BiotechnologyHealth CarePharmaceutical
Series AAug 8, 2021
Amount Raised: $7,250,000
Astrocyte Pharmaceuticals

Cambridge, Massachusetts, United States

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain injury patients.

BiotechnologyClinical TrialsPharmaceuticalTherapeutics
Series AMay 3, 2021
Amount Raised: $6,000,000